We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
AbOliGo is a biotechnology company developing next-generation antibodyoligonucleotide conjugates (AOCs) to unlock the power of multiomic analysis. Its proprietary conjugation platform delivers fast, reproducible and customizable AOCs for spatial biology, proteomics and single-cell workflows.
